Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) Against Oxidative Stress in Cardiovascular Related Diseases
Overview
Authors
Affiliations
Background: Nuclear factor-erythroid related factor-2 (Nrf2) is a master regulator of transcriptional activation of anti-oxidants in cells. Similarly, heme oxygenase (HO) is a cytoprotective protein with anti-oxidant effects. This review article will shed more light on the interaction between Nrf2 and HO.
Methods And Results: A PubMed search was done for recent articles on Nrf2 and HO. These studies suggested that under normal physiological conditions, Nrf2 is bound within the cytoplasm to its repressor, Kelch-like ECHassociated protein (Keap1), an oxidative stress sensor. Upon activation, Nrf2 translocates to the nucleus and binds to the antioxidant-response-element located at the promoter region of some anti-oxidants including the cytoprotective protein HO. Since the HO-1 gene harbors binding site for Nrf2, mutual stimulatory and regulatory effects between Nrf2 and HO-1 have been reported. Accordingly, the interaction between Nrf2 and HO-1 has been implicated in the regulation of many physiological anti-oxidants including superoxide dismutases, catalase, glutathione S-transferase, peroxidase, NAD(P)H quinone oxidoreductase, and thioredoxin.
Conclusion: Although an overwhelming body of evidence has underscored unique anti-oxidant attributes of HO- 1 and Nrf2, emerging evidence suggests that the cytoprotective activities of Nrf2 and HO-1 may be attributed, at least in part, to the potentiation of different anti-oxidants in physiological mileu. Since Nrf2 binds to the antioxidant responsive element of HO-1, the coordinated regulation of Nrf2 and keap1 by the HO-system may constitute the basis of many physiological effects of HO-1 including its effects against oxidative stress and inflammation in a wide spectrum of cardiovascular, cardio-metabolic and other related diseases.
Chaves A, Ventura R, Pacini M, Magalhaes N, Rodrigues e Silva P, Martins M Front Endocrinol (Lausanne). 2025; 16:1500630.
PMID: 39959616 PMC: 11827418. DOI: 10.3389/fendo.2025.1500630.
Tkaczenko H, Kurhaluk N Int J Mol Sci. 2025; 26(3).
PMID: 39940866 PMC: 11817741. DOI: 10.3390/ijms26031098.
Yousefi Zardak M, Keshavarz F, Mahyaei A, Gholami M, Moosavi F, Abbasloo E Sci Rep. 2024; 14(1):23074.
PMID: 39367100 PMC: 11452703. DOI: 10.1038/s41598-024-73075-7.
Zhu Q, Han Y, Wang X, Jia R, Zhang J, Liu M Gut Pathog. 2023; 15(1):62.
PMID: 38037141 PMC: 10688069. DOI: 10.1186/s13099-023-00586-5.
Feng Z, Huang Q, Zhang X, Xu P, Li S, Ma D PPAR Res. 2023; 2023:2523536.
PMID: 37020714 PMC: 10070030. DOI: 10.1155/2023/2523536.